Shengda Biotech announced that the company passed a share repurchase bill on July 24, and plans to use 16.5 million yuan to 30 million yuan to repurchase shares for employee stock ownership plans or share incentives. The repurchase period is until July 23, 2027. On July 29, for the first time, the company repurchased 184,600 shares through centralized bidding transactions, accounting for 0.10% of the total share capital. The repurchase price was 10.71 yuan/share - 10.86 yuan/share, and the total amount paid was 1.989 million yuan. The company will implement the repurchase in accordance with regulations and disclose the progress in a timely manner.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.